We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

(RTTNews) - Gilead Sciences Inc. (GILD) announced the pricing of senior unsecured notes in an aggregate principal amount of $3.5 billion, in an underwritten, registered public offering, consisting ...

Navigation apps already know where stop signs and traffic lights are located, mainly because vehicles on the road stop in front of them. These applications collect traffic data that help them ...

Night - Partly cloudy with a 56% chance of precipitation. Winds variable at 7 to 15 mph (11.3 to 24.1 kph). The overnight low will be 45 °F (7.2 °C). Partly cloudy with a high of 58 °F (14.4 ...

Gilead Sciences Inc (NASDAQ:GILD) stock is trading higher on Thursday after the company reported better-than-expected third-quarter financial results and raised its fiscal year 2024 guidance.

After massive market cap growth for Eli Lilly and Novo Nordisk since the start of the decade, investor enthusiasm dimmed for the two most valuable companies in the industry in the third quarter.

Ex-employee isn’t shielded by Pennsylvania’s whistleblower law Worker was told he’d be fired if he didn’t steal client’s memo An ex-Gilead worker who says he was illegally fired for refusing to steal ...

Today, a brief rundown of news from AstraZeneca, Amgen and Jazz Pharmaceuticals, as well as updates from Geron, Gilead Sciences and Avid Bioservices that you may have missed. Recent biotech company ...

Last month, Trodelvy’s bladder cancer ambitions were also derailed after Gilead decided to officially withdraw the treatment in that indication following a May miss in a confirmatory study ...

Cantor Fitzgerald analyst Olivia Brayer maintained a Hold rating on Gilead Sciences (GILD – Research Report) yesterday and set a price target of $80.00. The company’s shares closed yesterday ...